A. Kalliokoski
Oncology · 2009
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 8 citations into it
Whom A. Kalliokoski trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts A. Kalliokoski overall
Papers from A. Kalliokoski's perspective
Ordered by how strongly the researchers A. Kalliokoski trusts endorse each paper. Same corpus, a different order for every researcher.
- The superfamily of organic anion transporting polypeptides. (Biochimica et Biophysica Acta)
- Drug interactions with lipid‐lowering drugs: Mechanisms and clinical relevance (Clinical pharmacology and therapy)
- Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties (Pflügers Archiv)
- Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine (Clinical pharmacology and therapy)
- Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. (Gastroenterology)
- Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. (Biochemical and Biophysical Research Communications - BBRC)
- A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. (American Journal of Physiology - Gastrointestinal and Liver Physiology)
- SLCO1B1 variants and statin-induced myopathy--a genomewide study. (New England Journal of Medicine)
- Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. (Gastroenterology)
- Functional annotation of a full-length mouse cDNA collection (Nature)
Their papers
- Impact of OATP transporters on pharmacokinetics (2009) — 949 citations